The COVID Skin Gallery

Dr Bataille was instrumental in creating a Covid skin gallery of images with the support of the British Association of Dermatologists and Zoe Global LTD.

The gallery of images was collected via the COVID Symptom app as volunteers sent pictures of their rashes during the lockdown.

The gallery shows 8 types of rashes which can be found in 10% of swab positive subjects. More importantly, amongst those, the rash was the only sign if COVID infection in 21% of them. So it is important to be vigilant and any new rash, especially affecting the toes, must be regarded as a potential sign of COVID.

Although it is difficult to get a test with a skin rash only, it may be prudent to isolate, especially if you are in contact with people who are at risk of serious COVID. The gallery can be seen at

COVID Rashes Research

Since April 2020, Dr Bataille has carried out research on COVID rashes in collaboration with researchers at King’s College and the biotech company Zoe (

The data collected via the COVID symptom app in the UK has been invaluable for COVID research and rashes occur in 8% of COVID cases and of those, the rash was the only presentation. It is therefore important to recognise another important potential sign of COVID infection.

The manuscript is currently in pre-print and can be viewed here:

Other Links to COVID rashes research:

Teledermatology Service

Teledermatology Advice

Teledermatology opinion now available within 48 hours at The Medical Chambers Kensington

Urgent appointments with a Consultant Dermatologist can be difficult to get. Now, using remote telediagnosis, already available in many hospitals around the world, Dr Veronique Bataille can offer a rapid diagnosis of skin lesions/moles as well as rashes in under 48 hours in the private sector.

The Medical Chambers Kensington is one of the first private clinics to offer private teledermatology consultations for patients who need urgent advice.

How does it work?

One of our trained nurses available Monday to Saturday will see you as soon as possible at the Medical Chambers Kensington. The nurse will take a clinical history and several photographs of your skin lesion or rash including images with a specially designed instrument called a dermatoscope which magnifies the images x 20.

The nurse will then use a secure medical web-based system called eDerma, which has been designed by dermatologists, to send this information to Dr Veronique Bataille who will assesses remotely your history and images within 48 hours. Your history and images will then be part of your medical records and will be kept on the secure server. The service is not suitable for lesions in sensitive areas and the rash or lesion have to be visible on the day of the visit.

Dr Bataille will then make recommendations using the clinical information and photographs. These recommendations are sent to you (and your GP unless you opt out). You will be told if you need a face to face follow up appointment, treatment or biopsy or if there is nothing to worry about with no further treatment needed. Prescriptions can also be arranged remotely if necessary or you can take the PDF recommendation to your GP who can prescribe the medication if necessary.

Dr Bataille has used teledermatology in her NHS practice for over 14 years.

We look forward to welcoming you to the eDerma Teledermatology service at the Medical Chambers Kensington if you require an urgent opinion on a skin lesion/mole or a rash. Just make an appointment with our nurses by contacting the clinic directly by email: or telephone on 0207-2444200.

The cost of the teledermatology consultation is 125 pounds and the follow up consultation at the Medical Chambers if needed is 125 pounds. Please note that this is not covered by most insurance companies but any ongoing medical care including biopsies if needed will be covered when you show Dr Bataille’s recommendation to your insurance company. 

Further Information:

Genes for hair colour and skin’s ability to tan

Dr Bataille and her team have recently published two papers looking at genes for hair colour as well as genes having a role in the skin’s ability to tan. The high number of new genes discovered will help the field of skin cancer but also other areas of medicine as pigmentation of hair and skin is linked to other diseases.

2017 Publications

Dr Bataille continues to publish in high impact journals and was busy in 2017:

Ribero et al. Effects of sex on naevus body distribution and melanoma risk in two melanoma case-control studies at different latitudes. Brit J Dermatol 2017;176:1093-1094

Ribero et al. Acne and telomere length. A new spectrum between senescence and apoptosis pathways. J Invest Dermatol 2017;137:513-515

Ribero et al. Positive association between Vitamin D serum levels and naevus counts. Acta Derm Venereol 2017;10:321-324

Roos et al. Higher naevus count exhibits a distinct DNA methylation signature in healthy human skin: implications for melanoma. J Invest Dermatol 2017;137:910-920.

Puig-Butille JA et al. Genomic expression differences  between cutaneous cells from red hair color individuals and black hair color individuals based in bioinformatic analysis. Oncotarget 2017;14:11589-11599.

Law et al. Genome wide association shows that pigmentation genes play a role in skin aging. J Invest Dermatol 2017;137:1887-1894.

Zugna et al. Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients. Br J Cancer 2017;Nov 9 Ahead of print.

View more on the Publications page.

World Congress o Teledermatology

Dr Bataille has recently organized with 2 dermatology colleagues the World Congress of Teledermatology at the Royal College of Physicians in London. The meeting attracted dermatologists and nurses from 22 countries and showed the rapid expansion of mobile applications for the remote diagnosis of skin cancer in areas of the world where dermatologists are not easy to reach.

The need for expertise in the diagnosis of skin lesions remotely is bigger than ever as the development of phone applications for skin cancer screening has expanded rapidly over the last few years with applications from GPs to specialists but also consumers directly to specialists. These applications raised important issues regarding diagnosis, confidentiality, audits, data storage and many others which were discussed at the meeting with many eminent teledermatologists from all over the world.